Skip to content

    Clinical development

    Get to market faster with a unified, cloud-based clinical data acquisition and management system.

    Filters

    Showing results for


    Clear all
    Zelta user success stories: Less stress, lower database costs, and fast-tracked clinical trials

    Read about how Zelta brings database builds in-house, fast tracks clinical trials...

    By Jennifer Duff | 5 min. read

    How supervised machine learning optimizes AI use in clinical trials

    LLMs are frequently hailed as revolutionary tools in clinical trials. Read how...

    By Walker Bradham | 5 min. read

    Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses

    This article originally appeared on Pharmaceutical Technology.2025 is set to be...

    By Jennifer Duff | 7 min. read

    A toothy approach to innovating randomization in clinical trials

    In a recent webinar, Solventum revealed how the Zelta eClinical platform helped...

    By Jennifer Duff | 3 min. read

    The people-first approach transforming eClinical processes

    Adding a “human at the center” perspective can help optimize clinical data...

    By Kofi Darkoh | 3 min. read

    The benefits of using the same clinical trials platform across phases

    Sponsors can achieve greater efficiencies with a nimble clinical trials platform,...

    By Kofi Darkoh | 7 min. read

    Zelta ranks as Major Contender in Everest Group’s 2024 Clinical Data and Analytics PEAK Matrix report

    We’re excited to announce that Zelta has been positioned as a Major Contender in the...

    By Jennifer Duff | 3 min. read

    Let the use case decide: The Zelta way on AI and supervised machine learning

    For decades, when people thought of artificial intelligence (AI) what usually...

    By Walker Bradham | 2 min. read

    Zelta user success stories: Faster timelines, cleaner data, in-house flexibility

    This month we’re profiling just a few of the CROs, sponsors, biotech, and pharma...

    By Kofi Darkoh | 4 min. read

    Zelta ranked as a Leader in Everest Group’s 2024 EDC Products PEAK® Matrix Assessment

    We’re excited to announce that Zelta has been officially ranked as a Leader in the...

    By Jennifer Duff | 4 min. read

    Gene therapy: How Veristat cut trial database costs by 30%

    This piece originally appeared in Pharmaceutical Technology. The gene therapy...

    By Jennifer Duff | 7 min. read

    Untapped opportunities: Fulfilling the promise of decentralized clinical trials

    This piece originally appeared in Pharmaceutical Technology. The uptake of...

    By Wes Fishburne | 6 min. read

    4 ways the vaccine rush is defining infectious disease trends for CROs in 2024

    This piece originally appeared on Pharmaceutical Technology. The global healthcare...

    By Jennifer Duff | 5 min. read

    The future of Zelta on display at the 2024 User Conference

    That’s a wrap on the 2nd annual Zelta User Conference! We had a wonderful,...

    By Jennifer Duff | 5 min. read

    Oncology in 2024: The clinical trial trends reshaping the role of CROs

    This piece originally appeared on Pharmaceutical Technology. Oncology is the most...

    By Jennifer Duff | 7 min. read

    Four ways a holistic ecosystem for clinical trials can help boost ROI

    This piece originally appeared on Clinical Leader Clinical trials are complex and...

    By Jennifer Duff | 9 min. read

    Zelta surpasses 4,000 clinical trial studies

    February 2024 marked a major milestone for Zelta: the platform has now hosted over...

    By Jennifer Duff | 3 min. read

    Can Your Clinical Trial Design Handle Mid-Study Changes?

    As clinical research advances, the pharmaceutical and biotech industries...

    By Walker Bradham | 7 min. read

    Zelta expands its clinical trial ecosystem with a new partnership

    At Zelta, we understand that collaboration is the name of the game when it comes to...

    By Merative | 2 min. read

    Lifesaving oncology research deserves cutting-edge solutions

    The race to develop novel, advanced therapeutics for cancer patients is fast and...

    By Jennifer Duff | 7 min. read

    New report confirms Zelta by Merative is a Major Contender

    Merative has been named a Major Contender in Everest Group’s Life Sciences Clinical...

    By Shannon Reilly | 5 min. read

    Merative’s first year: Focus and progress

    Standing up Merative was a bold, complex move. To mark our first anniversary on 1...

    By Gerry McCarthy | 4 min. read

    Three years after COVID-19, the conversation around DCTs is shifting again

    While interest in decentralized clinical trials (DCTs) has been heating up lately,...

    By Wes Fishburne | 6 min. read

    The disconnect between clinical trial technology and legacy habits

    In today’s age of cloud computing and data integration solutions, there are simple...

    By Jennifer Duff | 4 min. read

    Merative Clinical Development has a new name

    General Manager Jennifer Duff describes what the new name means for Merative’s...

    By Jennifer Duff | 2 min. read

    Connecting with the clinical development community

    The time it takes to design, launch and complete clinical trials is a problem many...

    By Jennifer Duff | 2 min. read

    Will DCTs finally democratize clinical trials?

    Zelta Product Leader Walker Bradham and Senior Product Manager Wes Fishburne...

    By Walker Bradham | 4 min. read